Merck & Co., Inc. Stock Price Sees 3.9% Increase Amid Institutional Investor Buying
Merck & Co., Inc. (NYSE:MRK) has seen its stock price increase by 3.9% as of August 17-21, with a market capitalization of $386.22 billion and a PE ratio of 125.23.
The company's most recent filing with the Securities and Exchange Commission shows that Plato Investment Management Ltd increased its position in Merck & Co., Inc.'s shares by 15.3% during the second quarter, owning 74,299 shares worth $9,492,000 as of July 2025.
In other news, EVP Richard R. Deluca sold 20,784 shares at an average price of $130.43 on August 10th, and EVP David R. Maraldo sold 18,706 shares at $128.72 on August 5th, both representing a decrease in their ownership.
The company has set its FY 2026 guidance at 2.660-2.760 EPS, and analysts expect it to post 2.76 earnings per share for the current fiscal year.